Table 2.
Study assessment schedule.
| Measures | EMA | Baseline | Pre-TX | During Tx | Post-Tx | 3-Month | 6-Month |
|---|---|---|---|---|---|---|---|
| Demographic Information | X | ||||||
| Pain and Treatment History | X | ||||||
| Start Back Tool | X | ||||||
| Pain Medication Questionnaire (PMQ) | X | ||||||
| Roland Morris Disability Questionnaire SF (RMDQ) | X | ||||||
| PROMIS Pain Interference | X | X | X | X | X | ||
| Pain Appraisal Scale (PAS) | X | X | X | X | X | ||
| 2-item Catastrophizing Scale from the Coping Strategy Questionnaire (CSQ) | X | X | X | X | |||
| Non-Judgment Scale from the Pain-Related Cognitive Process Questionnaire (PCPQ) | X | X | X | X | X | ||
| Godin Leisure-Time Exercise Questionnaire | X | X | X | X | X | ||
| Hours Spent Sitting w/o Exercising | X | ||||||
| Pain Intensity NRS | X | X | X | X | X | X | |
| Positive and Negative Affect Schedule (PANAS) | X | X | X | X | X | ||
| PROMIS Sleep Disturbance | X | X | X | X | |||
| PROMIS Physical Function | X | X | X | X | |||
| PROMIS Depression | X | X | X | X | |||
| PROMIS Anxiety | X | X | X | X | |||
| PTSD Checklist (PCL-C) | X | X | X | X | |||
| Medication Use | X | X | X | X | |||
| UW Pain-Related Self-Efficacy Scale | X | X | X | X | X | ||
| Participant Engagement | Xa | ||||||
| Working Alliance Inventory (WAI) | Xb | ||||||
| Group Climate Questionnaire (GSQ-S) | Xb | ||||||
| Duration and Times Practicing Skills | X | X | X | X | |||
| Sleep/Wake Times | X | ||||||
| Health Care Utilization | X | X | X | X | |||
| Pleasant Events Schedule SF | X | X | X | X | |||
| Behavioral Activation for Depression Scale (BADS) | X | X | X | X | |||
| Global Quality of Life | X | X | X | X | |||
| Employment Status | X | X | X | X | |||
| Weight | X | X | X | X | |||
| Mindful Awareness and Attention Scale (MAAS) | X | X | X | X | |||
| Pain Resilience Scale | X | X | X | X | |||
| Pain-Related Cognitive Process Questionnaire (PCPQ) – Full | X | X | X | X | |||
| Control, Harm, Disability and Medication scales from the Survey of Pain Attitudes (SOPA) | X | X | X | X | |||
| PROMIS Cognitive Function Abilities | X | X | X | X | |||
| COVID-19 Impact Questions (as of 2020) | X | X | X | X | |||
| Treatment Credibility and Expectancies | Xc | ||||||
| Patient Global Impression of Change (PGIC) | X | X | X | ||||
| Patient Global Assessment of Treatment Satisfaction (PGATS) | X | X | X | ||||
| Treatment Modality & Preferences | X | ||||||
| Qualitative Outcomes | X | ||||||
| Optional: Positive & Negative Response to Pain Scales, Future Self Questionnaire (FSQ), Valued Living Scale (VLS) | X | X | X | X |
a
Will be assessed for each participant and reported by the clinician following every treatment session.
b
Will be assessed during the evening EMA following Sessions 4 & 8 only.
c
Will be assessed once before Session 1 and once following Session 1 but before Session 2.